Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company offers allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It provides its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.
Beximco Pharmaceuticals Dividend Announcement
• Beximco Pharmaceuticals announced a annually dividend of £2.08 per ordinary share which will be made payable on 2025-02-01. Ex dividend date: 2024-11-22
• Beximco Pharmaceuticals annual dividend for 2024 was £2.08
• Beximco Pharmaceuticals annual dividend for 2023 was £2.34
• Beximco Pharmaceuticals's trailing twelve-month (TTM) dividend yield is -%
• Beximco Pharmaceuticals's payout ratio for the trailing twelve months (TTM) is 29.69%
• Beximco Pharmaceuticals's dividend growth over the last five years (2018-2023) was 11.15% year
Beximco Pharmaceuticals Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-11-22 | £2.08 | annually | 2025-02-01 |
2023-11-10 | £2.34 | annually | 2024-02-08 |
2022-11-17 | £2.67 | annually | 2023-03-27 |
2021-11-18 | £3.45 | annually | 2022-02-15 |
2020-11-23 | £1.71 | annually | 2021-01-27 |
2019-11-21 | £1.61 | annually | 2020-02-04 |
2018-11-21 | £1.38 | annually | 2019-02-11 |
2017-11-13 | £1.37 | annually | 2018-02-22 |
2016-10-28 | £0.66 | annually | |
2016-05-10 | £1.17 | annually | |
2015-05-19 | £1.05 | annually | |
2009-05-20 | £0.01 | annually | |
2008-06-30 | £0.00 | annually |
Beximco Pharmaceuticals Dividend per year
Beximco Pharmaceuticals Dividend growth
Beximco Pharmaceuticals Dividend Yield
Beximco Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Beximco Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:
Beximco Pharmaceuticals Financial Ratios
Beximco Pharmaceuticals Dividend FAQ
Other factors to consider when evaluating Beximco Pharmaceuticals as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Beximco Pharmaceuticals stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Beximco Pharmaceuticals's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Beximco Pharmaceuticals publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Beximco Pharmaceuticals distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Beximco Pharmaceuticals are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Beximco Pharmaceuticals sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Beximco Pharmaceuticals distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Beximco Pharmaceuticals declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Beximco Pharmaceuticals's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Beximco Pharmaceuticals's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.